KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Non-cash Items (2016 - 2023)

Historic Non-cash Items for Teladoc Health (TDOC) over the last 11 years, with Q1 2023 value amounting to $23.8 million.

  • Teladoc Health's Non-cash Items fell 8517.14% to $23.8 million in Q1 2023 from the same period last year, while for Mar 2023 it was $23.8 million, marking a year-over-year decrease of 8517.14%. This contributed to the annual value of $23.7 million for FY2022, which is 64609.41% up from last year.
  • Latest data reveals that Teladoc Health reported Non-cash Items of $23.8 million as of Q1 2023, which was down 8517.14% from $23.7 million recorded in Q4 2022.
  • Over the past 5 years, Teladoc Health's Non-cash Items peaked at $1.1 billion during Q4 2020, and registered a low of $3.1 million during Q1 2020.
  • For the 5-year period, Teladoc Health's Non-cash Items averaged around $295.3 million, with its median value being $204.0 million (2019).
  • In the last 5 years, Teladoc Health's Non-cash Items tumbled by 9935.33% in 2019 and then surged by 2407282.72% in 2021.
  • Teladoc Health's Non-cash Items (Quarter) stood at $308.5 million in 2019, then skyrocketed by 245.16% to $1.1 billion in 2020, then crashed by 77.22% to $242.6 million in 2021, then tumbled by 90.23% to $23.7 million in 2022, then rose by 0.42% to $23.8 million in 2023.
  • Its Non-cash Items stands at $23.8 million for Q1 2023, versus $23.7 million for Q4 2022 and $23.8 million for Q3 2022.